BNP Paribas Asset Management
HALO icon

BNP Paribas Asset Management’s Halozyme HALO Stock Holding History

BNP Paribas Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.91M Sell
122,330
-24,640
-17% -$1.74M 0.01% 745
2025
Q4 		$9.89M Buy
146,970
+145,729
+11,743% +$9.8M 0.01% 683
2025
Q3 		$91K Buy
1,241
+43
+4% +$2.86K ﹤0.01% 875
2025
Q2 		$62K Buy
+1,198
New +$68.2K ﹤0.01% 1069
2021
Q3 		– Sell
-8,233
Closed -$374K – 900
2021
Q2 		$374K Buy
+8,233
New +$364K ﹤0.01% 837

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Asset Management's HALO Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Halozyme (HALO) stake by 17% in Q1 2026, selling an estimated $1.74M and leaving 122,330 shares worth $7.91M. The position accounts for 0.01% of the portfolio, ranked #745.

BNP Paribas Asset Management first reported a position in HALO in Q2 2021 and has held it in 5 quarters since. The position peaked at $9.89M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • BNP Paribas Asset Management held 122,330 shares of Halozyme worth $7.91M as of Q1 2026.
  • BNP Paribas Asset Management sold 24,640 Halozyme shares in Q1 2026, an estimated $1.74M.
  • Halozyme made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #745 holding.
  • BNP Paribas Asset Management first reported a position in Halozyme in Q2 2021 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Halozyme position peaked at $9.89M in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.